CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 74 enrolled
Drug / intervention
Acyclovir +1 moredrug
Likely dose
Acyclovir 200mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02053142
NCT02053142N/ACompleted
CompareCT.gov

Prospective Study of Pharmacokinetics, Clinical and Virologic Response to Acyclovir Episodic Therapy for Genital Herpes Ulcers in HIV Negative African Women

University of North Carolina, Chapel Hill·interventional·Posted Feb 3, 2014·Updated Sep 15, 2017

In Brief

A clinical study evaluating Acyclovir and Placebo for Ulcers of Female Genital Organs. Completed, enrolled 74 participants across 1 site.

Detailed Summary

This is a prospective study to evaluate the pharmacokinetics, clinical and virologic response to acyclovir episodic therapy for genital herpes ulcers in HIV negative African women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUlcers of Female Genital Organs
CountriesZambia
CollaboratorsNational Institute of Allergy and Infectious Diseases (NIAID)

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 3, 2014
Enrollment StartJan 1, 2009
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 12.4 years ago

Interventions

Acyclovirdrug

Single dose of acyclovir 200mg was given for pk study

Placebodrug